Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

Missouri · checked against MO HealthNet GLP-1 obesity criteria (revised Apr 23, 2026)

Does Missouri Medicaid Cover Wegovy or Zepbound? 2026 GLP-1 Rules

Yes, with prior authorization. MO HealthNet covers Zepbound and Foundayo for obesity: BMI 30 or more, or 27 or more with a condition such as high blood pressure, prediabetes or sleep apnea. Wegovy is non-preferred and covered only for heart risk or MASH, not for weight loss. Ozempic and Mounjaro are preferred for diabetes.

What to do next

  • Medicaid: check the criteria below, then ask your doctor to request prior authorization.
  • Medicare: ask your prescriber about the GLP-1 Bridge.
  • Job-based plan: call the number on your insurance card.

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

Coverage in Missouri at a glance

Medicaid
Weight loss: Zepbound, Foundayo with PA
  • Wegovy: heart risk or MASH only
  • Ozempic, Mounjaro: preferred for diabetes

Source: MO HealthNet / Missouri DSS, checked Oct 22, 2026 · Rules

Medicare
Bridge: $50/mo

Source: CMS, checked Oct 17, 2026 · Rules

By GLP1-US Editorial TeamUpdated

01 Medicaid

MO HealthNet Covers Zepbound and Foundayo for Obesity

Anti-obesity drugs were historically excluded from MO HealthNet. On January 9, 2025 Missouri began covering select GLP-1s for obesity through a state preferred drug list edit; the April 23, 2026 revision lists Foundayo, Zepbound and Zepbound KwikPen as preferred and Wegovy as non-preferred. Drugs used only for obesity that are not on this list stay excluded.

Zepbound or Foundayo for obesity: meet one

  1. 1BMI 30 or more

    (adults)

  2. 2BMI 27 or more with a condition

    High blood pressure, high cholesterol, sleep apnea, prediabetes (A1C 5.7 to 6.4%), prior heart attack or stroke, symptomatic PAD, or type 2 diabetes

  3. 3MASH

    F2 or F3 fibrosis by recent biopsy or noninvasive tests

  4. 4Antipsychotic therapy

    Documented concurrent antipsychotic treatment

  5. 5Teens

    Age 12 to 17 (Zepbound) with BMI at or above the 95th percentile

Yes to allDefault approval: 90 days. Foundayo is 18+; no two GLP-1s at once.

No to oneSee cash prices below.Cash prices

Sources: MO HealthNet SmartPA Criteria Proposal, "GLP-1 Receptor Agonists Indicated for Obesity PDL Edit," first implemented January 9, 2025, revised April 23, 2026; GLP-1 PA form 2575-053 (April 2026). Other states: Medicaid GLP-1 coverage by state.

02 Wegovy

Wegovy in Missouri: Heart Risk or MASH Only

The PA form is direct: Wegovy for reduction of excess body weight or long-term weight maintenance is not covered by MO HealthNet. Two uses are.

  • Heart risk: age 45+, BMI 27 or more, prior heart attack, stroke or symptomatic PAD, on heart medication, and no diabetes (no diagnosis or diabetes drugs in 2 years, A1C under 6.5% within 3 months)
  • MASH: age 18+, F2 or F3 fibrosis, current liver tests, specialist prescriber, no diabetes
  • Approvals run 4 weeks at a time until the dose reaches at least 1.7 mg; therapy is denied if that dose is not reached within 6 months

Diabetes: Byetta, Mounjaro, Ozempic, Trulicity and Victoza are preferred with a diabetes diagnosis; non-preferred GLP-1s need three preferred drugs tried for 3 months each. PA line (800) 392-8030, fax (573) 636-6470.

03 Medicare

Medicare in Missouri: the $50 GLP-1 Bridge

Medicare is national, so Missouri Part D members get the same Bridge terms as every state, with prior authorization from the prescriber.

$50/mo
copay per fill
Jul 1, 2026 to Dec 31, 2027
program window
Covered
Wegovy (pen, HD and tablets), Zepbound KwikPen, Foundayo
Not covered
Ozempic, Mounjaro, Zepbound vials

BMI tiers and enrollment steps: Medicare GLP-1 Bridge.

04 Cash prices

Cash Prices for Missourians

Missouri has no state GLP-1 price program, so self-pay prices are the national manufacturer prices, as of October 2026.

DrugSelf-pay per monthChannel
Wegovy tablets$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)NovoCare
Foundayofrom $149 (0.8 mg), up to $299LillyDirect
Zepbound vial or KwikPen$299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) with a refill within 45 daysLillyDirect
Wegovy pen$199 for the first 2 fills at 0.25 or 0.5 mg (new patients, through Dec 31, 2026), then $349; Wegovy HD $399NovoCare
Mounjaro (diabetes)$499 minimum with the savings card, no coverageLilly savings card

All drugs and channels: GLP-1 cost.

05 Telehealth

Telehealth Providers Serving Missouri

Online programs whose own site says they serve Missouri patients, with visit fee and drug type; full comparison on best GLP-1 providers 2026.

Online GLP-1 programs that say they serve Missouri, Oct 2026
ProgramInsurance
PlushCare
Copay (typically $30 or less) or $129 self-pay
All 50 states and DC (help center). FDA-approved brands, filled at your pharmacy.
Takes insurance
Mochi Health
Health membership $79/mo ($0 first month for new members) or $49/mo on a 12-month plan; with qualifying insurance, membership from $17/mo plus $0 to $30 visit copays
Anywhere in the US (FAQ). Medication availability and price vary by state.
Takes insurance
Found
$79 to $289/mo (insurance track) or $149 to $339/mo (cash track, medication included)
Insurance map lists 42 states, this one included. Some prescriptions not available in all states.
Takes insurance
Calibrate
$199/mo membership, 3-month minimum ($597)
All 50 states and DC (FAQ). Brand GLP-1s billed to insurance.
Takes insurance
MEDvidi
$195 initial, $159 follow-up; weight-loss package $249
Named in its list of 35 states. Some states require an in-person visit.
Cash only
IvyRx
Free consultation
All 50 states (help center, Dec 2024). Compounded semaglutide.
Cash only
Eden
Included (no membership fees)
GLP-1 programs in all 50 states (FAQ). Compounded only.
Cash only
ShedRx
Bundled
All 50 states (FAQ). Treatment availability varies by state.
Cash only

8 programs whose own site states they serve Missouri, state lists re-read Oct 23, 2026. Programs that publish no state list (including Ro, Hims, Henry Meds and WeightWatchers) are not shown; that does not mean they are unavailable. Amazon One Medical lists weight care in 48 states and DC without naming the two excluded states.

06 FAQ

Missouri GLP-1 Coverage FAQ

Does Missouri Medicaid cover Zepbound for weight loss?
Yes. Since January 9, 2025 MO HealthNet covers Zepbound (and since the 2026 revision Foundayo) for obesity with PA: BMI 30 or more, or 27 or more with a weight-related condition. Approvals default to 90 days.
Does Missouri Medicaid cover Wegovy for weight loss?
No. MO HealthNet covers Wegovy only to reduce heart risk (age 45+, BMI 27+, established heart disease, no diabetes) or to treat MASH, approved 4 weeks at a time during dose increases.
Are Ozempic and Mounjaro covered by MO HealthNet?
Yes, both are preferred GLP-1s for members with a diabetes diagnosis.
Can Missouri Medicare members get Wegovy or Zepbound for $50?
Yes, if they qualify for the federal Medicare GLP-1 Bridge: Part D coverage, a qualifying BMI tier and a prior authorization from the prescriber. From July 1, 2026 to December 31, 2027 the copay is $50 a month for Wegovy, Zepbound KwikPen or Foundayo. The rules are the same in every state.

07 Other states

GLP-1 Coverage in Other States

All 50 states and DC side by side: Medicaid GLP-1 coverage by state. National background: does Medicaid cover weight loss shots. On an employer plan or Medicare instead of Medicaid? Rules by insurer: Medicare, Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, Kaiser Permanente.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

Checked against primary sources such as FDA labels, CMS and provider pages
Updated
How we check facts →